End-to-end scientific study modules built to satisfy international GLP, OECD, and ICH guidelines for worldwide regulatory dossier readiness.
Addressing the critical risk parameters, compliance demands, and analytical requirements modern biopharmaceutical and nutraceutical brand directors encounter.
Global procurement directors require toxicological validation aligned directly with US FDA IND enabling packages, EFSA novel food thresholds, and NMPA safety standards. MedGence eliminates audit rejections through reproducible, audited data outputs.
Unlike single-molecule synthetics, complex botanical fractions require specialized toxicity assessment addressing synergetic toxicokinetics, heavy metal bioaccumulation, and trace degradation impurities across multi-herb combinations.
Enterprise clients face tight go-to-market deadlines. Our parallelized screening pipelines compress pre-clinical toxicity milestones from months to weeks without compromising Good Laboratory Practice (GLP) methodological integrity.
Outsourcing mission-critical toxicology demands rigorous intellectual property firewalls. MedGence operates on an entrusted, blind-coded research model ensuring your extract fractionations and formula designs remain fully confidential.
A systematic framework bridging traditional ethnobotanical pharmacology and modern quantitative molecular toxicology.
Botanicals harvested across divergent regional terrains present fluctuating metabolite levels that skew toxicology reproducibility. MedGence solves this via HPTLC, HPLC, GC-MS, and chromatographic fingerprinting to establish absolute baseline batch equivalence before toxicity evaluations commence.
Traditional toxicity assays often fail to catch subtle organ-specific pathologies. We incorporate advanced biomarker panels covering renal clearance biomarkers, hepatic enzyme induction (CYP450), and neurotoxicity screens to deliver complete human translation profiles.
A toxicity study is meaningless if the validated process cannot be manufactured cleanly at scale. MedGence connects safety validation directly with internal pilot-scale extraction facilities, guaranteeing commercial batches match tested safety profiles identically.
A structured, modular progression designed to de-risk active botanical substances systematically from cellular assay to regulatory dossier.
High-throughput cellular viability assays (MTT/LDH), membrane leakage evaluation, and preliminary dose-range finding on target human tissue cell lines.
Deliverable: IC50 Cytotoxicity ProfileOECD-compliant battery testing: Bacterial Reverse Mutation (Ames Test), In Vitro Mammalian Chromosomal Aberration, and Micronucleus screening assays.
Deliverable: Genotoxicity Report PackageDetermination of acute systemic toxicity (LD50 / acute oral), repeated-dose 28-day and 90-day sub-chronic rodent studies evaluating organ pathology and blood biochemistry.
Deliverable: NOAEL Determination DossierCompilation of audited toxicokinetic parameters, histopathology analyses, safety margins, and clinical dose projection documentation for NDA/IND filings.
Deliverable: Global Regulatory Safety FileOur verifiable operational metrics represent 14+ years of dedicated natural medicine CRO & CDMO execution.
Enabling direct market entry across the North American, European, and Asia-Pacific healthcare sectors.
Toxicity datasets are structured to support New Dietary Ingredient (NDI) notifications, Self-Affirmed Generally Recognized as Safe (GRAS) expert panels, and Botanical Drug Development Guidance compliance packages.
Execution of genotoxicity testing and repeated-dose toxicological assessments aligned with EFSA guidance for novel food applications and EMA Committee on Herbal Medicinal Products (HMPC) monograph benchmarks.
Direct translation for China NMPA health food registration, Australian TGA complementary medicine listings, and PMDA Japanese functional food safety files, minimizing repetitive overseas regional studies.
Our collaborative research network spans over 100 industrial manufacturers and tier-one academic medical centers.
Tongrentang Group
CR Sanjiu
Sunflower Pharma
Livzon Group
Dihon Pharma
Golden Throat
Yangtzi River
Gofar Chuanshan
Humanwell Health
SCIMYTH Group
Shuguang Hospital
Second Xiangya
Essential guidance on study parameters, timeline considerations, and cross-border regulatory compliance.
Connect with our technical research team to discuss project requirements, sample testing workflows, and custom service scopes.
